Strategic Prioritization of Inflammatory Indications: Navigating Risk, Reward & Clinical Feasibility
Time: 3:30 pm
day: Conference Day One PM
Details:
- Analyzing the trade-offs between orphan inflammatory indications vs larger markets with complex disease heterogeneity
- Reviewing how disease prevalence and competitive activity influences early pipeline decisions
- Unlocking real-world examples on how strategic indication shifts impact drug development opportunities
